4-butyrolactone has been researched along with Neoplasms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cherek, P; Jóhannsson, F; Ögmundsdóttir, HM; Rolfsson, Ó; Xu, M | 1 |
| Deng, L; Jin, Y; Liu, H; Liu, J; Tzeng, YM; Wang, F; Xing, H | 1 |
| Brzostek, T; Del Rio, D; Favari, C; Galvano, F; Gniadek, A; Godos, J; Grosso, G; Libra, M; Mena, P; Micek, A | 1 |
| Bhat, C; Goovaerts, H; Kiuru, P; Mäki-Lohiluoma, E; Moreels, L; Pardo, LA; Peigneur, S; Tytgat, J; Voráčová, M; Yli-Kauhaluoma, J; Zahed, F | 1 |
| Chang, CM; Chen, YS; Chen, YT; Chern, J; Fang, Z; Hua, KF; Lam, Y; Lu, CP; Ng, CY; Wu, SH | 1 |
| Anant, S; Hegde, MV; Kadam, SS; Mali, AV; Padhye, SB | 1 |
| Banerjee, S; Bose, D; Chatterjee, N; Das, S; Saha, KD; Saha, M | 1 |
| Bach Knudsen, KE; Eriksen, AK; Frederiksen, K; Kyrø, C; Landberg, R; Nørskov, NP; Olsen, A; Overvad, K; Tjønneland, A | 1 |
| Hu, Y; Huang, Y; Jiang, L; Jin, W; Liu, K; Sheikh, MS; Shen, X; Sun, Q | 1 |
| Lajis, NH; Phillips, R; Sagineedu, SR; Sidik, SM; Stanslas, J; Sumon, SH; Wong, CC | 1 |
| Basabe, P; Díez, D; Lithgow, A; Marcos, IS; Padrón, JM; Plata, GB; Urosa, A | 1 |
| Jones, J; Liu, Z; Reger, MK; Zhang, J; Zollinger, TW | 1 |
| Bolvig, AK; Christensen, J; Eriksen, AK; Knudsen, KE; Kyrø, C; Nørskov, NP; Olsen, A; Tjønneland, A | 1 |
| Greenberg, EP; Oliver, CM; Schaefer, AL; Sufrin, JR | 1 |
| Cao, X; Dai, J; Ge, H; Shen, Y; Xie, D; Zou, J | 1 |
| Fujita, Y; Ito, M; Mizuguchi, Y; Nakagawa, K; Okano, T; Yamano, Y; Yoshida, M | 1 |
| Chen, JM; Power, KA; Saarinen, NM; Thompson, LU | 1 |
| Colomer, R; Lupu, R; Menéndez, JA | 1 |
| Adlercreatz, H; Anderson, LC; Axelson, M; Borriello, SP; Gordon, H; Harkness, R; Kirk, DN; Lawson, AM; Morgan, DM; Setchell, KD | 1 |
| Griffiths, K; Morton, MS; Wahlqvist, ML; Wilcox, G | 1 |
| Adlercreutz, H | 1 |
3 review(s) available for 4-butyrolactone and Neoplasms
| Article | Year |
|---|---|
Dietary phytoestrogens and biomarkers of their intake in relation to cancer survival and recurrence: a comprehensive systematic review with meta-analysis.
Topics: 4-Butyrolactone; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diet; Eating; Female; Humans; Isoflavones; Lignans; Male; Middle Aged; Neoplasms; Phytoestrogens; Young Adult | 2021 |
Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.
Topics: 4-Butyrolactone; Animals; Humans; Lignans; Neoplasm Metastasis; Neoplasms | 2019 |
Phyto-oestrogens and cancer.
Topics: 4-Butyrolactone; Animals; Breast Neoplasms; Diet; Estrogens, Non-Steroidal; Female; Glycine max; Humans; Isoflavones; Lignans; Male; Neoplasms; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Tumor Cells, Cultured | 2002 |
18 other study(ies) available for 4-butyrolactone and Neoplasms
| Article | Year |
|---|---|
The Anti-Proliferative Lichen-Compound Protolichesterinic Acid Inhibits Oxidative Phosphorylation and Is Processed via the Mercapturic Pathway in Cancer Cells.
Topics: 4-Butyrolactone; Cell Proliferation; Glutathione; Lichens; Neoplasms; Oxidation-Reduction; Oxidative Phosphorylation; Reactive Oxygen Species | 2022 |
Application of Multiple Strategies to Improve the Production of the Potential Cancer Drug 4-Acetylantroquinonol B (4-AAQB) by the Rare Fungus Antrodia cinnamomea.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cyclohexanones; Neoplasms; Polyporales | 2022 |
Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancer-relevant potassium channel KV10.1.
Topics: 3T3 Cells; 4-Butyrolactone; Animals; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Mice; Neoplasms; Potassium Channel Blockers | 2017 |
Affinity-Driven Covalent Modulator of the Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Cascade.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Cell Line, Tumor; Drug Resistance, Neoplasm; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Mice; Models, Molecular; Neoplasms; Signal Transduction; Tandem Mass Spectrometry | 2018 |
Inhibition of TGF-β induced lipid droplets switches M2 macrophages to M1 phenotype.
Topics: 4-Butyrolactone; Animals; Cell Line, Tumor; Cytokines; Female; Humans; Lipid Droplets; Macrophages; Male; Mice; Mice, Inbred BALB C; Neoplasms; Nitric Oxide; Phenotype; RAW 264.7 Cells; Reactive Oxygen Species; THP-1 Cells; Tumor Microenvironment | 2019 |
Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort.
Topics: 4-Butyrolactone; Aged; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Lignans; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation | 2019 |
Lappaol F, a novel anticancer agent isolated from plant arctium Lappa L.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Apoptosis; Arctium; Benzofurans; Cell Cycle Checkpoints; Cell Line, Tumor; Humans; Mice; Neoplasms; Plant Extracts; Xenograft Model Antitumor Assays | 2014 |
NCI in vitro and in silico anticancer screen, cell cycle pertubation and apoptosis-inducing potential of new acylated, benzylidene and isopropylidene derivatives of andrographolide.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; BH3 Interacting Domain Death Agonist Protein; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Survival; Diterpenes; Drug Screening Assays, Antitumor; HCT116 Cells; Heterocyclic Compounds, 3-Ring; Humans; In Vitro Techniques; MCF-7 Cells; Models, Molecular; National Cancer Institute (U.S.); Neoplasms; Signal Transduction; United States | 2014 |
Synthesis and bioactivity of Luffarin I.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Australia; Cell Line, Tumor; Cell Proliferation; Diterpenes; Furans; Humans; Indicators and Reagents; Molecular Conformation; Molecular Structure; Neoplasms; Osmolar Concentration; Pacific Ocean; Porifera; Sesterterpenes; Stereoisomerism | 2015 |
Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey.
Topics: 4-Butyrolactone; Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Isoflavones; Lignans; Male; Middle Aged; Mortality; Neoplasms; Nutrition Surveys; Phytoestrogens; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2016 |
Use of antibiotics is associated with lower enterolactone plasma concentration.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Body Mass Index; Cohort Studies; Exercise; Female; Gastrointestinal Microbiome; Humans; Life Style; Lignans; Linear Models; Male; Middle Aged; Neoplasms; Nutrition Assessment; Risk Factors; Surveys and Questionnaires; Tandem Mass Spectrometry; Time Factors | 2016 |
Microwave synthesis and evaluation of phenacylhomoserine lactones as anticancer compounds that minimally activate quorum sensing pathways in Pseudomonas aeruginosa.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Microwaves; Neoplasms; Pseudomonas aeruginosa; Quorum Sensing; Spectrometry, Mass, Electrospray Ionization | 2009 |
Butyrolactone and cycloheptanetrione from mangrove-associated fungus Aspergillus terreus.
Topics: 4-Butyrolactone; Antineoplastic Agents; Aspergillus; Azepines; Cell Line, Tumor; Cell Survival; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Spectrometry, Mass, Electrospray Ionization; Tropolone | 2012 |
Biological activities of retinoidal gamma-hydroxybutenolides in cancer cell apoptosis and differentiation.
Topics: 4-Butyrolactone; Apoptosis; Cell Differentiation; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Hydrogen; Molecular Structure; Neoplasms; Transcription, Genetic; Tretinoin | 2005 |
Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice.
Topics: 4-Butyrolactone; Animals; Apoptosis; Body Weight; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Feeding Behavior; Genistein; Humans; Lignans; Mice; Mice, Nude; Neoplasms; Ovariectomy; Xenograft Model Antitumor Assays | 2006 |
An easy, rapid and objective mathematical method to identify fatty acid synthase (oncogenic antigen-519) modulators with potential anticancer value.
Topics: 4-Butyrolactone; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Models, Theoretical; Neoplasms; RNA Interference | 2008 |
Lignan formation in man--microbial involvement and possible roles in relation to cancer.
Topics: 4-Butyrolactone; Bacteria; Butylene Glycols; Clostridium; Depression, Chemical; Female; Humans; Intestines; Lignans; Male; Menstruation; Metronidazole; Neoplasms; Oxytetracycline; Plant Extracts; Pregnancy | 1981 |
Determination of lignans and isoflavonoids in human female plasma following dietary supplementation.
Topics: 4-Butyrolactone; Australia; Chromans; Diet; Equol; Estrogens; Female; Food, Fortified; Gas Chromatography-Mass Spectrometry; Genistein; Glycine max; Humans; Isoflavones; Lignans; Linseed Oil; Middle Aged; Monoamine Oxidase Inhibitors; Neoplasms; Plants, Edible; Postmenopause | 1994 |